...
首页> 外文期刊>Diabetes >Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring
【24h】

Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring

机译:妊娠期间母体血清25-羟基维生素D的水平以及后代1型糖尿病的风险

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies indicate reduced risk of type 1 diabetes after intake of vitamin D supplements during pregnancy or early childhood. We aimed to test whether lower maternal serum concentrations of 25-hydroxy-vitamin D (25-OH D) during pregnancy were associated with an increased risk of childhood-onset type 1 diabetes. In this case-control study nested within a cohort of 29,072 women in Norway, 25-OH D levels were measured using a radioirnmunoassay on samples from late pregnancy in 109 women delivering a child who developed type 1 diabetes before 15 years of age (case subjects) and from 219 control women. Dividing the levels of maternal 25-OH D into quartiles, there was a trend toward a higher risk of type 1 diabetes with lower levels of vitamin D during pregnancy. The odds of type 1 diabetes was more than twofold higher for the offspring of women with the lowest levels of 25-OH D compared with the offspring of those with levels above the upper quartile. Given future replication in independent cohorts, our findings provide support for the initiation of a randomized intervention trial to prevent type 1 diabetes in children by enhancing maternal 25-OH D status during pregnancy.
机译:先前的研究表明,在怀孕或儿童早期摄入维生素D补充剂后1型糖尿病的风险降低。我们旨在测试孕期孕妇血清中25-羟基维生素D(25-OH D)的降低是否与儿童期1型糖尿病的患病风险增加相关。在这项病例对照研究中,挪威的一组29,072名妇女中,使用放射免疫分析法对109名分娩的,在15岁之前发展为1型糖尿病的儿童的妊娠晚期妇女进行了放射免疫测定,测定了25-OH D水平(病例) ),并从219位对照女性中选出。将孕妇的25-OH D水平分为四分位数,趋势是妊娠期间维生素D含量较低的1型糖尿病风险较高。 25-OH D水平最低的妇女的后代与上四分位数以上妇女的后代相比,其1型糖尿病的几率高出两倍以上。考虑到未来在独立队列中的复制,我们的发现为通过加强孕妇在孕期的25-OH D状态来预防儿童1型糖尿病的随机干预试验提供了支持。

著录项

  • 来源
    《Diabetes》 |2012年第1期|p.175-178|共4页
  • 作者单位

    Department of Pediatrics, Oslo University Hospital Ulleval, Oslo, Norway;

    Department of Pediatrics, Oslo University Hospital Ulleval, Oslo, Norway,Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway;

    Department of Medical Microbiology, Vestre Viken Hospital Trust, Rud, Norway;

    Department of Obstetrics and Gynecology, Akershus University Hospital, Oslo, Norway,Institute of Clinical Medicine, University of Oslo, Oslo, Norway;

    Hormone Laboratory, Oslo University Hospital Aker, Oslo, Norway;

    Norwegian Institute of Public Health, Oslo, Norway;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号